The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares Northwest Biotherapeutics, Inc (NASDAQ:NWBO) shares was launched over potential breaches of fiduciary duties by certain officers and directors at Northwest Biotherapeutics.
Investors who purchased shares of Northwest Biotherapeutics, Inc (NASDAQ:NWBO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Northwest Biotherapeutics, Inc (NASDAQ:NWBO officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
On June 19, 2014, an article was published that stated that “The prestigious MD Anderson Cancer Center issued a stern rebuke to Northwest Biotherapeutics (NWBO) for making promotional, unjustified claims about results from an ongoing clinical trial of an experimental cancer vaccine known as DCVax-Direct.” Shares of Northwest Biotherapeutics, Inc (NASDAQ:NWBO) declined to $6.25 per share on July 11, 2014.
Those who purchased shares of Northwest Biotherapeutics, Inc (NASDAQ:NWBO), have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com